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Background
Neurons of the striatum receive important glutaminergic
input from the cortex and thalamus and massive dopami-
nergic innervation from midbrain dopamine neurons. The
majority (95%) of striatal neurons are medium spiny pro-
jection neurons and 5% are aspiny interneurons. The pro-
jection neurons are GABAergic and form the direct and
indirect striatal output pathways that have been shown to
be crucial for normal motor function and appetitively
motivated learning. The importance of the medium spiny
projection neurons is highlighted by the severe debilitation
associated with the loss of their dopaminergic input in
Parkinson’s disease or degeneration of these cells in Hun-
tington’s disease (Kreitzer, Ann Rev Neurosci, 32, 127-147,
2009). Approximately half of all medium spiny striatal
neurons express the dopamine D1A receptor (Drd1a) and
these neurons comprise the direct output pathway to the
medial globus pallidus and substantia nigra pars reticulata
(Valjent et al., TINs, 32, 538-547, 2009). Early deletion of
the Drd1-expressing striatal neurons in mice results in
severe motor impairment, eating deficits and reduced
striatal volume (Drago, et al., J Neurosci, 18, 9845-9857,
1998). In order to separate potential developmental effects
from the normal role of the Drd1a-expressing striatal cells
in adult mice, we have made a mouse model that allows
for the inducible deletion or expression of targeted genes
specifically within the Drd1a-expressing striatal neurons
using BAC transgenesis.
Methods
A bacterial artificial chromosome (BAC) designated
RP23-47M2 was obtained from BACPAC resources of
the Children’s Hospital Oakland Research Institute
(CHORI). This BAC contains the Drd1a locus. Using the
techniques of bacterial homologous recombination (Liu,
et al., Genome Res, 13, 476-484, 2003), a cassette con-
taining the reverse tetracycline-controlled transactivator
(rtTA) fused to the herpes simplex virus VP16 transacti-
vator was inserted at the ATG start site of the Drd1a
locus. Transgenic mice with the modified BAC randomly
integrated into their genomes were produced by microin-
jection of the modified BAC into mouse zygotes at the
University of Michigan Transgenic Core. Transgenic
mouse lines carrying the rtTA allele were crossed with
reporter transgenic mice carrying the allele for tetO-lacZ.
In bi-transgenic mice this approach (TET-ON) allows for
the activation of the tet operator by rtTA in the presence
of doxycycline (DOX). Therefore, during DOX adminis-
tration, the lacZ gene produces b-galactosidase which
can be detected through X-gal staining.
Results
Drd1a-rtTA/tetO-lacZ lines were screened and at least
one line to date has shown strong expression specifically
within the mouse striatum. X-gal staining is present
throughout the striatum, with somewhat higher levels in
the medial aspects of the structure. We are continuing
to screen additional lines and are determining the mini-
mal parameters of DOX administration (dose and dura-
tion) necessary for the inducible expression of rtTA/
VP16.
Conclusion
We have made the first inducible Drd1a TET-ON
mouse. This mouse, in conjunction with other trans-
genic models, will allow for the inducible expression or
deletion of target genes specifically within Drd1a-expres-
sing cells and will be highly useful in the study of Par-
kinson’s and Huntington’s diseases, addiction and the
normal role of Drd1a-expressing cells.
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